Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

SELL
$80.93 - $108.63 $785,668 - $1.05 Million
-9,708 Reduced 43.56%
12,579 $1.3 Million
Q3 2022

Nov 03, 2022

BUY
$82.16 - $96.94 $1.57 Million - $1.86 Million
19,146 Added 609.55%
22,287 $1.89 Million
Q2 2022

Aug 08, 2022

SELL
$71.48 - $86.85 $1.1 Million - $1.33 Million
-15,364 Reduced 83.03%
3,141 $260,000
Q1 2022

May 09, 2022

BUY
$74.28 - $92.69 $1.37 Million - $1.72 Million
18,505 New
18,505 $1.43 Million
Q2 2021

Aug 09, 2021

SELL
$75.51 - $84.79 $2.18 Million - $2.45 Million
-28,895 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$74.73 - $90.69 $2.16 Million - $2.62 Million
28,895 New
28,895 $2.18 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.